Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;27(8):563.
doi: 10.1177/1533317512464118.

Alzheimer's disease--emerging new potential therapeutic modalities

Shailendra Kapoor

Alzheimer's disease--emerging new potential therapeutic modalities

Shailendra Kapoor. Am J Alzheimers Dis Other Demen. 2012 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Similar articles

See all similar articles

References

    1. Salloway S, Mintzer J, Cummings JL, Geldmacher D, Sun Y, Yardley J, Mackell J. Subgroup analysis of US and Non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe alzheimer's disease. In press. - PMC - PubMed
    1. Tohda C, Urano T, Umezaki M, Nemere I, Kuboyama T. Diosgenin is an exogenous activator of 1,25D(3)-MARRS/Pdia3/ERp57 and improves Alzheimer's disease pathologies in 5XFAD mice. Sci Rep. 2012;2:535. - PMC - PubMed
    1. Xu J, Kurup P, Nairn AC, Lombroso PJ. Striatal-enriched protein tyrosine phosphatase in Alzheimer's disease. Adv Pharmacol. 2012;64:303–325. - PMC - PubMed
    1. Ma K, Thomason LA, McLaurin J. Scyllo-inositol, preclinical, and clinical data for Alzheimer's disease. Adv Pharmacol. 2012;64:177–212. - PubMed
    1. Wolfe MS. Gamma-secretase as a target for Alzheimer's disease. Adv Pharmacol. 2012;64:127–153. - PubMed